Literature DB >> 7797929

Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma.

L J Hayes1, S Pecharatana, R L Bailey, T J Hampton, M A Pickett, D C Mabey, P J Watt, M E Ward.   

Abstract

Variants of Chlamydia trachomatis in two Gambian villages with hyperendemic trachoma were analyzed by omp1-based polymerase chain reaction and sequencing from conjunctival swabs. Samples collected over a 22-month period included a complete cross-sectional study of each village. Overall, 4 genovar A and 4 B variants were characterized by point mutations in the omp1 gene, resulting in changes in the inferred amino acid sequence. Two genovar A and 2 B variants accounted for 87% of the total ocular chlamydial infection in both villages. Although some flux in the prevalence of individual variants was observed overtime, their overall distribution remained remarkably stable. There was no evidence of major antigenic shift arising from recombination events at the omp1 locus as described for genital tract infection. These results indicate that omp1 variation in these two trachoma-hyperendemic communities is limited and unlikely to hamper development of trachoma vaccines based on the major outer membrane protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797929     DOI: 10.1093/infdis/172.1.268

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Phylogenetic analysis of Chlamydia trachomatis.

Authors:  D Dean; K Millman
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

2.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

3.  Late-stage inclusion body conjunctivitis: trachoma?

Authors:  Martin Zinkernagel; Elena Catalano; Dagmar Ammann-Rauch
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

4.  Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.

Authors:  M Johansson; K Schön; M Ward; N Lycke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease.

Authors:  D Dean; K Millman
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

6.  Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1).

Authors:  C I Bandea; K Kubota; T M Brown; P H Kilmarx; V Bhullar; S Yanpaisarn; P Chaisilwattana; W Siriwasin; C M Black
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

7.  Recombination in the ompA gene but not the omcB gene of Chlamydia contributes to serovar-specific differences in tissue tropism, immune surveillance, and persistence of the organism.

Authors:  K L Millman; S Tavaré; D Dean
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

8.  Use of a reverse dot blot procedure to identify the presence of multiple serovars in Chlamydia trachomatis urogenital infection.

Authors:  D R Stothard
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 9.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin.

Authors:  Jose Paolo V Magbanua; Beng Tin Goh; Claude-Edouard Michel; Aura Aguirre-Andreasen; Sarah Alexander; Ines Ushiro-Lumb; Catherine Ison; Helen Lee
Journal:  Sex Transm Infect       Date:  2007-06-13       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.